Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

Summary

Co-Diagnostics and ReadyGo announced a collaboration to evaluate blood-based molecular testing using the Co-Dx PCR platform combined with GoCollect sample preparation, targeting decentralized Ebola detection as the initial application with potential expansion to HIV and hepatitis B and C testing.